Evidence map›Paper›PMID 34867914›Full record

ArticleFrontiers in microbiology2021

Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin.

Joan Bacqué, Elena Delgado, Sonia Benito, María Moreno-Lorenzo, Vanessa Montero, Horacio Gil, Mónica Sánchez, María Carmen Nieto-Toboso, Josefa Muñoz, Miren Z Zubero-Sulibarria and 12 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 1 country.

Joan BacquéHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Elena DelgadoHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Sonia BenitoHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
María Moreno-LorenzoHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Vanessa MonteroHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Horacio GilHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Mónica SánchezHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
María Carmen Nieto-TobosoHospital Universitario de Basurto, Bilbao, Spain.
Josefa MuñozHospital Universitario de Basurto, Bilbao, Spain.
Miren Z Zubero-SulibarriaHospital Universitario de Basurto, Bilbao, Spain.
Estíbaliz UgaldeHospital Universitario de Basurto, Bilbao, Spain.
Elena García-BodasHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Javier E CañadaHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Jorge Del RomeroCentro Sanitario Sandoval, IdISSC, Madrid, Spain.
Carmen RodríguezCentro Sanitario Sandoval, IdISSC, Madrid, Spain.
Iciar Rodríguez-AvialHospital Clínico San Carlos, Madrid, Spain.
Luis Elorduy-OtazuaHospital Universitario de Cruces, Barakaldo, Spain.
José J PortuHospital Universitario de Araba, Vitoria, Spain.
Juan García-CostaComplejo Hospitalario Universitario de Ourense, Ourense, Spain.
Antonio OcampoComplejo Hospitalario Universitario de Vigo, Vigo, Spain.
Jorge J CabreraComplejo Hospitalario Universitario de Vigo, Vigo, Spain.
Michael M ThomsonHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Centro Nacional de Microbiologia · ESInstituto de Salud Carlos III · ESHospital de Basurto · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESUniversity Hospital Complex Of Vigo · ESComplejo Hospitalario de Ourense · ESHospital Clínico San Carlos · ESHospital de Cruces · ESHospital Universitario Araba · ES

Funding

Autism Speaks AS2021
6 · The paper itself

Abstract

Circulating recombinant forms (CRFs) are important components of the HIV-1 pandemic. Among 110 reported in the literature, 17 are BF1 intersubtype recombinant, most of which are of South American origin. Among these, all 5 identified in the Southern Cone and neighboring countries, except Brazil, derive from a common recombinant ancestor related to CRF12_BF, which circulates widely in Argentina, as deduced from coincident breakpoints and clustering in phylogenetic trees. In a HIV-1 molecular epidemiological study in Spain, we identified a phylogenetic cluster of 20 samples from 3 separate regions which were of F1 subsubtype, related to the Brazilian strain, in protease-reverse transcriptase (Pr-RT) and of subtype B in integrase. Remarkably, 14 individuals from this cluster (designated BF9) were Paraguayans and only 4 were native Spaniards. HIV-1 transmission was predominantly heterosexual, except for a subcluster of 6 individuals, 5 of which were men who have sex with men. Ten additional database sequences, from Argentina (

Indexed as

circulating recombinant formHIV-1molecular epidemiologyphylodynamicsphylogeny

Identifiers

PMID34867914
PMCPMC8634668
OpenAlexW3214157683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.